News
FLGT
20.75
+0.24%
0.05
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
NASDAQ · 17h ago
Fulgent Genetics: Statement of changes in beneficial ownership of securities
Press release · 1d ago
Weekly Report: what happened at FLGT last week (0422-0426)?
Weekly Report · 3d ago
Weekly Report: what happened at FLGT last week (0415-0419)?
Weekly Report · 04/22 10:52
Weekly Report: what happened at FLGT last week (0408-0412)?
Weekly Report · 04/15 10:45
Press Release: Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024. Management will host a conference call for the investment community the same day. Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. The company will release its first quarter 2024 financial results before the market opens.
Dow Jones · 04/11 20:10
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Fulgent Genetics, Inc. Will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024. Management will host a conference call for the investment community the same day to discuss the results. Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business.
Barchart · 04/11 15:05
Weekly Report: what happened at FLGT last week (0401-0405)?
Weekly Report · 04/08 10:49
Weekly Report: what happened at FLGT last week (0325-0329)?
Weekly Report · 04/01 10:47
Fulgent Genetics: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Press release · 03/28 00:24
Weekly Report: what happened at FLGT last week (0318-0322)?
Weekly Report · 03/25 10:49
Weekly Report: what happened at FLGT last week (0311-0315)?
Weekly Report · 03/18 10:48
Weekly Report: what happened at FLGT last week (0304-0308)?
Weekly Report · 03/11 10:46
Fulgent Genetics: Correspondence
Press release · 03/08 16:05
Fulgent Genetics Price Target Cut to $25.00/Share From $28.00 by Piper Sandler
Dow Jones · 03/06 14:42
Fulgent Genetics Is Maintained at Neutral by Piper Sandler
Dow Jones · 03/06 14:42
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $25
Benzinga · 03/06 14:31
Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)
TipRanks · 03/06 12:36
U.S. RESEARCH ROUNDUP-Arrivent Biopharma, Ferguson, Target
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Arrivent Biopharma, Ferguson and Target among companies with revised targets. Ferguson, Target and Box are among the companies with new analyst coverage. Analysts raised their ratings on Arrivent, Ferguson, and Target.
Reuters · 03/06 06:47
Weekly Report: what happened at FLGT last week (0226-0301)?
Weekly Report · 03/04 10:48
More
Webull provides a variety of real-time FLGT stock news. You can receive the latest news about Fulgent Genetics through multiple platforms. This information may help you make smarter investment decisions.
About FLGT
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.